SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,691,523 | +9.8% | 1,985,576 | +3.8% | 0.01% | +8.3% |
| Q2 2023 | $219,160,589 | -10.4% | 1,913,732 | +7.9% | 0.01% | -14.3% |
| Q1 2023 | $244,506,927 | -51.4% | 1,773,976 | -54.3% | 0.01% | -6.7% |
| Q4 2022 | $503,222,376 | +135.3% | 3,883,488 | +100.7% | 0.02% | +7.1% |
| Q3 2022 | $213,893,000 | +23.2% | 1,934,983 | -16.5% | 0.01% | +40.0% |
| Q2 2022 | $173,644,000 | +8.0% | 2,316,483 | +12.6% | 0.01% | +25.0% |
| Q1 2022 | $160,746,000 | -4.2% | 2,057,675 | +10.4% | 0.01% | 0.0% |
| Q4 2021 | $167,795,000 | +1.2% | 1,863,355 | +4.0% | 0.01% | -11.1% |
| Q3 2021 | $165,733,000 | +26.4% | 1,792,094 | +6.3% | 0.01% | +28.6% |
| Q2 2021 | $131,096,000 | -13.4% | 1,686,345 | -17.0% | 0.01% | -22.2% |
| Q1 2021 | $151,393,000 | -52.2% | 2,031,305 | +9.3% | 0.01% | -52.6% |
| Q4 2020 | $316,953,000 | +18.8% | 1,859,072 | -2.1% | 0.02% | +5.6% |
| Q3 2020 | $266,712,000 | -9.4% | 1,899,252 | +3.4% | 0.02% | -14.3% |
| Q2 2020 | $294,375,000 | +46.5% | 1,835,945 | -10.7% | 0.02% | +16.7% |
| Q1 2020 | $201,000,000 | -22.8% | 2,054,794 | +1.8% | 0.02% | 0.0% |
| Q4 2019 | $260,456,000 | +57.7% | 2,018,411 | -8.0% | 0.02% | +50.0% |
| Q3 2019 | $165,181,000 | -20.1% | 2,193,055 | +61.1% | 0.01% | -20.0% |
| Q2 2019 | $206,802,000 | +28.2% | 1,360,988 | +0.6% | 0.02% | +15.4% |
| Q1 2019 | $161,320,000 | +18.5% | 1,353,466 | +8.5% | 0.01% | +8.3% |
| Q4 2018 | $136,125,000 | -31.7% | 1,247,364 | +1.0% | 0.01% | -20.0% |
| Q3 2018 | $199,378,000 | +2.8% | 1,234,470 | -15.9% | 0.02% | -6.2% |
| Q2 2018 | $193,967,000 | +17.5% | 1,467,473 | -34.2% | 0.02% | +14.3% |
| Q1 2018 | $165,142,000 | +25.0% | 2,228,988 | -6.1% | 0.01% | +27.3% |
| Q4 2017 | $132,117,000 | -0.4% | 2,374,461 | -18.8% | 0.01% | 0.0% |
| Q3 2017 | $132,614,000 | +24.3% | 2,923,542 | -7.6% | 0.01% | +22.2% |
| Q2 2017 | $106,699,000 | +12.7% | 3,165,146 | -1.0% | 0.01% | +12.5% |
| Q1 2017 | $94,641,000 | +30.8% | 3,197,127 | +21.2% | 0.01% | +14.3% |
| Q4 2016 | $72,352,000 | -60.2% | 2,637,785 | -10.9% | 0.01% | -61.1% |
| Q3 2016 | $181,762,000 | +208.2% | 2,959,911 | -4.3% | 0.02% | +200.0% |
| Q2 2016 | $58,976,000 | +22.4% | 3,092,427 | +25.3% | 0.01% | +20.0% |
| Q1 2016 | $48,168,000 | -22.0% | 2,467,376 | +54.0% | 0.01% | -28.6% |
| Q4 2015 | $61,793,000 | +43.1% | 1,601,718 | +19.1% | 0.01% | +40.0% |
| Q3 2015 | $43,185,000 | -10.1% | 1,345,031 | -14.8% | 0.01% | 0.0% |
| Q2 2015 | $48,047,000 | +65.5% | 1,579,119 | -27.7% | 0.01% | +66.7% |
| Q1 2015 | $29,023,000 | +8.1% | 2,185,564 | +17.8% | 0.00% | 0.0% |
| Q4 2014 | $26,856,000 | -2.0% | 1,855,989 | +42.9% | 0.00% | 0.0% |
| Q3 2014 | $27,402,000 | -14.5% | 1,298,541 | +20.7% | 0.00% | 0.0% |
| Q2 2014 | $32,042,000 | +4.8% | 1,075,444 | -15.4% | 0.00% | 0.0% |
| Q1 2014 | $30,568,000 | -32.0% | 1,271,942 | -37.3% | 0.00% | 0.0% |
| Q4 2013 | $44,983,000 | -14.8% | 2,027,138 | +81.2% | 0.00% | -57.1% |
| Q3 2013 | $52,825,000 | +45.0% | 1,118,545 | +16.8% | 0.01% | +40.0% |
| Q2 2013 | $36,432,000 | – | 957,437 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |